Gastrointestinal Adverse Reactions In the pool of placebo-controlled trials, gastrointestinal adverse reactions occurred more frequently among patients receiving OZEMPIC than placebo (placebo 15.3%, OZEMPIC 0.5 mg 32.7%, OZEMPIC 1 mg 36.4%)
Thats because Rybelsus works by slowing digestion and reducing appetite
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Your prescriber might recommend stepping down to a lower dose temporarily and re-titrating up, which is the same approach used during initial treatment
You may notice subtle changes, like feeling full faster or experiencing mild nausea
It helps the body produce insulin more effectively and controls blood sugar levels while also reducing appetite, often leading to weight loss